| Response Biomedical Corporation (TSX: RBM, OTCBB:RPBIF) announced today the appointment Dr. David Wang of Orbimed Asia to the Board of Directors of Response Biomedical, the resignation of Dr. Jonathan Wang as a Director of Response Biomedical, and the promotion of two executives to leadership positions in the Company. Board Changes Pursuant to the OrbiMed agreement dated June 27, 2010, Response granted OrbiMed Private Investments III, LP two designees on the Response Board of Directors. Dr. David...continued RBM:CA RPBIF Electronics Technology Technology |
Thursday, October 20, 2011
Response Biomedical Corporation Announces Leadership Changes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment